Northern Trust Corp Kymera Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 384,175 shares of KYMR stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

384,175

Previous 368,141 4.36%

Holding current value

$15.6 Million

Previous $11 Million 65.47%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$30.16 - $52.4 $483,585 - $840,181	16,034 Added 4.36%	384,175 $18.2 Million
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $138,653 - $183,105	-4,645 Reduced 1.25%	368,141 $11 Million
Q1 2024 May 14, 2024	BUY	$22.9 - $43.57 $325,340 - $618,998	14,207 Added 3.96%	372,786 $15 Million
Q4 2023 Feb 13, 2024	SELL	$10.97 - $26.84 $84,205 - $206,023	-7,676 Reduced 2.1%	358,579 $9.13 Million
Q3 2023 Nov 13, 2023	BUY	$13.9 - $23.88 $157,445 - $270,488	11,327 Added 3.19%	366,255 $5.09 Million
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $405,462 - $632,086	18,101 Added 5.37%	354,928 $8.16 Million
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $114,611 - $178,792	-4,614 Reduced 1.35%	336,827 $9.98 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $189,887 - $300,016	9,703 Added 2.92%	341,441 $8.52 Million
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $34,292 - $56,202	-1,640 Reduced 0.49%	331,738 $7.22 Million
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $190,868 - $574,765	13,508 Added 4.22%	333,378 $6.56 Million
Q1 2022 May 13, 2022	SELL	$35.3 - $64.68 $671,759 - $1.23 Million	-19,030 Reduced 5.62%	319,870 $13.5 Million
Q4 2021 Feb 08, 2022	BUY	$49.91 - $65.56 $8,834 - $11,604	177 Added 0.05%	338,900 $21.5 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $3.79 Million - $5.28 Million	79,208 Added 30.52%	338,723 $19.9 Million
Q2 2021 Aug 13, 2021	BUY	$31.08 - $51.95 $4.41 Million - $7.38 Million	142,014 Added 120.86%	259,515 $12.6 Million
Q1 2021 May 12, 2021	SELL	$35.64 - $85.46 $157,707 - $378,160	-4,425 Reduced 3.63%	117,501 $4.57 Million
Q4 2020 Feb 11, 2021	BUY	$28.07 - $87.83 $3.42 Million - $10.7 Million	121,926 New	121,926 $7.56 Million

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Kymera Therapeutics, Inc. Transaction History